<div id="readability-page-1"><p><span>Envista (NYSE:NVST - Get Free Report)</span> was upgraded by stock analysts at Barclays to a &#34;strong-buy&#34; rating in a research report issued to clients and investors on Monday, MarketBeat.com reports.</p><p>Other equities analysts have also recently issued research reports about the stock. Stifel Nicolaus  set a $25.00 price objective on shares of Envista in a research note on Thursday, October 30th. Mizuho  set a $19.00 price target on shares of Envista in a report on Monday, November 3rd. Robert W. Baird  set a $27.00 price target on shares of Envista in a research report on Friday, October 31st. Zacks Research lowered Envista from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Monday, September 15th. Finally, Wall Street Zen raised shares of Envista from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research note on Saturday, November 1st. Two investment analysts have rated the stock with a Strong Buy rating, four have issued  a Buy rating, eight have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $21.54.</p><p><b>Read Our Latest Report on Envista</b></p><h2>Envista Stock Performance</h2><p>NVST opened at $20.61 on Monday. Envista has a 12-month low of $14.22 and a 12-month high of $22.68. The firm has a market capitalization of $3.39 billion, a P/E ratio of 229.06, a price-to-earnings-growth ratio of 0.98 and a beta of 1.02. The stock's 50 day moving average price is $20.08 and its two-hundred day moving average price is $20.05. The company has a quick ratio of 2.02, a current ratio of 2.37 and a debt-to-equity ratio of 0.47. </p><p>Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.05. Envista had a net margin of 0.58% and a return on equity of 5.90%. The company had revenue of $669.90 million for the quarter, compared to the consensus estimate of $639.49 million. During the same quarter in the previous year, the firm posted $0.12 EPS. The business's revenue was up 11.5% compared to the same quarter last year.  On average, equities analysts forecast that  Envista will post 1 earnings per share for the current year. </p><h2>Institutional Investors Weigh In On Envista</h2><p>A number of large investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC raised its position in shares of  Envista by 317.6% in the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company's stock valued at $27,000 after purchasing an additional 1,026 shares during the period.  Caitong International Asset Management Co. Ltd increased its position in  Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company's stock worth $31,000 after buying an additional 1,504 shares during the period.  MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of  Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company's stock worth $44,000 after buying an additional 949 shares in the last quarter.  SJS Investment Consulting Inc. increased its position in  Envista by 10,356.5% during the third quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company's stock worth $49,000 after acquiring an additional 2,382 shares during the period.  Finally, EverSource Wealth Advisors LLC raised its stake in  Envista by 378.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company's stock worth $47,000 after purchasing an additional 1,909 shares in the last quarter. </p><h2>Envista Company Profile</h2> (Get Free Report)<p>Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products &amp; Technologies, and Equipment &amp; Consumables. The Specialty Products &amp; Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.</p><h2>Read More</h2><ul><li>Five stocks we like better than Envista</li><li>Conference Calls and Individual Investors</li><li>Insiders Are Selling These 3 Stocks—Here’s Why</li><li>Options Trading - Understanding  Strike Price</li><li>Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers</li><li>Canada Bond Market Holiday: How to Invest and Trade </li><li>10X Gains? These 3 Robotics Stocks Could Explode by 2035</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5WU1Q?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU5WU1Q"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Envista Right Now?</h2><p>Before you consider Envista, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.</p><p>While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

NVST

<p>Barclays upgraded Envista (NYSE:NVST) to a "strong-buy" rating, reflecting positive investment research. Other analysts have varied opinions, with some setting price targets between $19 and $27. Envista's stock opened at $20.61, with a market cap of $3.39 billion. Recent earnings exceeded expectations, and institutional investors have adjusted their positions. Envista develops dental products globally, operating in two segments: Specialty Products & Technologies, and Equipment & Consumables.</p>

Barclays Upgrades Envista (NYSE:NVST) to "Strong-Buy"